Announcements Trials

Browse Landscape

Phase

Status

Completed 9 Terminated 5 Withdrawn 1 Unknown 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5 Other hematologic neoplasm 2 Lymphoid 2 Thoracic 1 Plasma cell 1 Head & Neck 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

pembrolizumab 78 Fulvestrant 76 Carboplatin 74 Trastuzumab 71 Capecitabine 70 Letrozole 63 Cyclophosphamide 61 Paclitaxel 60 Specimen Handling 54 pertuzumab 52 Docetaxel 50 abemaciclib 46 ribociclib 45 Anastrozole 36 Magnetic Resonance Spectroscopy 35 130-nm albumin-bound paclitaxel 35 trastuzumab deruxtecan 34 Blood Specimen Collection 33 exemestane 32 Tamoxifen 32 Biopsy 32 sacituzumab govitecan 31 Gemcitabine 30 Epirubicin 29 pyrotinib 28 palbociclib 28 Drug Therapy 28 Surveys and Questionnaires 27 Injections 27 eribulin 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Mental Status and Dementia Tests × Breast × Clear all

NCT06582615 2025-12-11

MIND-TNBC

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡